Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02987829
Brief Title: Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

First Submitted : December 5, 2016
First Submitted that Met QC Criteria : December 8, 2016
First Posted : December 9, 2016 (Estimate)

Results First Submitted : March 1, 2021
Results First Posted with QC Comments : March 26, 2021
Results First Submitted that Met QC Criteria : March 29, 2021
Results First Posted : April 23, 2021

Last Update Submitted that Met QC Criteria : March 29, 2021
Last Update Posted : April 23, 2021